Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Globus Medical Reaffirms FY25 Revenue Guidance Of $2.80B - $2.90B And Non-GAAP EPS Of $3.00 - $3.30

Author: Benzinga Newsdesk | July 21, 2025 07:13am

Posted In: GMED

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist